Literature DB >> 24904097

Socioeconomic disparities in lymphoma.

Christopher R Flowers1, Loretta J Nastoupil2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24904097      PMCID： PMC4047493          DOI： 10.1182/blood-2014-04-568766

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Improving outcomes for patients with diffuse large B-cell lymphoma.

Authors:  Christopher R Flowers; Rajni Sinha; Julie M Vose
Journal:  CA Cancer J Clin       Date:  2010-10-28       Impact factor: 508.702

2.  Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities.

Authors:  Richard B Warnecke; April Oh; Nancy Breen; Sarah Gehlert; Electra Paskett; Katherine L Tucker; Nicole Lurie; Timothy Rebbeck; James Goodwin; John Flack; Shobha Srinivasan; Jon Kerner; Suzanne Heurtin-Roberts; Ronald Abeles; Frederick L Tyson; Georgeanne Patmios; Robert A Hiatt
Journal:  Am J Public Health       Date:  2008-07-16       Impact factor: 9.308

3.  Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.

Authors:  Bertrand Coiffier; Catherine Thieblemont; Eric Van Den Neste; Gérard Lepeu; Isabelle Plantier; Sylvie Castaigne; Sophie Lefort; Gérald Marit; Margaret Macro; Catherine Sebban; Karim Belhadj; Dominique Bordessoule; Christophe Fermé; Hervé Tilly
Journal:  Blood       Date:  2010-06-14       Impact factor: 22.113

4.  Genetic heterogeneity of diffuse large B-cell lymphoma.

Authors:  Jenny Zhang; Vladimir Grubor; Cassandra L Love; Anjishnu Banerjee; Kristy L Richards; Piotr A Mieczkowski; Cherie Dunphy; William Choi; Wing Yan Au; Gopesh Srivastava; Patricia L Lugar; David A Rizzieri; Anand S Lagoo; Leon Bernal-Mizrachi; Karen P Mann; Christopher Flowers; Kikkeri Naresh; Andrew Evens; Leo I Gordon; Magdalena Czader; Javed I Gill; Eric D Hsi; Qingquan Liu; Alice Fan; Katherine Walsh; Dereje Jima; Lisa L Smith; Amy J Johnson; John C Byrd; Micah A Luftig; Ting Ni; Jun Zhu; Amy Chadburn; Shawn Levy; David Dunson; Sandeep S Dave
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-04       Impact factor: 11.205

5.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

6.  Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.

Authors:  Pareen J Shenoy; Neha Malik; Ajay Nooka; Rajni Sinha; Kevin C Ward; Otis W Brawley; Joseph Lipscomb; Christopher R Flowers
Journal:  Cancer       Date:  2010-12-22       Impact factor: 6.860

7.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Wing C Chan; Joseph M Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend B Smeland; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan L Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

8.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Insurance status is related to diffuse large B-cell lymphoma survival.

Authors:  Xuesong Han; Ahmedin Jemal; Christopher R Flowers; Helmneh Sineshaw; Loretta J Nastoupil; Elizabeth Ward
Journal:  Cancer       Date:  2014-01-28       Impact factor: 6.860

10.  Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.

Authors:  Li Tao; James M Foran; Christina A Clarke; Scarlett L Gomez; Theresa H M Keegan
Journal:  Blood       Date:  2014-04-04       Impact factor: 25.476
  10 in total
  16 in total

1.  Health Insurance-Related Disparities in Lymphoma Survival Are Partly Mediated by Baseline Clinical Factors.

Authors:  Adam J Olszewski; James M Foran
Journal:  Oncologist       Date:  2015-10-02

Review 2.  To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes.

Authors:  Jean L Koff; Dai Chihara; Anh Phan; Loretta J Nastoupil; Jessica N Williams; Christopher R Flowers
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

Review 3.  New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy.

Authors:  Dai Chihara; Loretta J Nastoupil; Jessica N Williams; Paul Lee; Jean L Koff; Christopher R Flowers
Journal:  Expert Rev Anticancer Ther       Date:  2015-04-11       Impact factor: 4.512

4.  Insurance status impacts overall survival in Burkitt lymphoma.

Authors:  Jordan S Goldstein; Jeffrey M Switchenko; Madhusmita Behera; Christopher R Flowers; Jean L Koff
Journal:  Leuk Lymphoma       Date:  2019-07-05

5.  Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma.

Authors:  Michelle J Lee; Jean L Koff; Jeffrey M Switchenko; C Ileen Jhaney; R Andrew Harkins; Sharvil P Patel; Sandeep S Dave; Christopher R Flowers
Journal:  Cancer       Date:  2020-05-29       Impact factor: 6.860

Review 6.  Next-generation prognostic assessment for diffuse large B-cell lymphoma.

Authors:  Ashley D Staton; Jean L Koff; Qiushi Chen; Turgay Ayer; Christopher R Flowers
Journal:  Future Oncol       Date:  2015-08-20       Impact factor: 3.404

7.  Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma.

Authors:  Qiushi Chen; Turgay Ayer; Loretta J Nastoupil; Jean L Koff; Ashley D Staton; Jagpreet Chhatwal; Christopher R Flowers
Journal:  Leuk Lymphoma       Date:  2015-12-15

8.  Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.

Authors:  Amy A Ayers; Lin Lyu; Kaylin Dance; Kevin C Ward; Christopher R Flowers; Jean L Koff; Lauren E McCullough
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-06-26

9.  Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma.

Authors:  S Hong; L Rybicki; D M Abounader; B J Bolwell; R Dean; A T Gerds; B K Hamilton; B T Hill; D Jagadeesh; M Kalaycio; H D Liu; B Pohlman; R Sobecks; N S Majhail
Journal:  Bone Marrow Transplant       Date:  2016-04-25       Impact factor: 5.483

10.  Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.

Authors:  Chandrayee Sarker; Vivek S Radhakrishnan; Payal Mandal; Jeevan Kumar; Saurabh Bhave; Rimpa Achari; Debdeep Dey; Indu Arun; Zameer Latif; Neeraj Arora; Deepak Mishra; Mammen Chandy; Reena Nair
Journal:  Ecancermedicalscience       Date:  2021-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.